Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
73 hedge funds and large institutions have $47.1M invested in Marrone Bio Innovations, Inc. in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 25 reducing their positions, and 8 closing their positions.
25% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 8
1% more funds holding
Funds holding: 72 → 73 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
24% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 25
48% less capital invested
Capital invested by funds: $91.4M → $47.1M (-$44.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OFA
Oak Family Advisors
Chicago,
Illinois
|
+$751K |
| 2 |
UIC
Uniplan Investment Counsel
Milwaukee,
Wisconsin
|
+$628K |
| 3 |
Renaissance Technologies
New York
|
+$330K |
| 4 |
SC
Shay Capital
New York
|
+$313K |
| 5 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
+$248K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$3.16M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
-$719K |
| 3 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$482K |
| 4 |
Millennium Management
New York
|
-$400K |
| 5 |
PCM
Penserra Capital Management
Orinda,
California
|
-$321K |
MBII Hedge Fund Activity: Q3 2021 in Review
73 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q3 2021, worth a combined $47.1M — down 48% from $91.4M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new MBII positions and 8 closed out — a net gain of 2 holders — while 19 added to existing stakes and 25 trimmed.
The largest buyer was Oak Family Advisors, opening a new position worth an estimated $751K. The largest seller was Macquarie Group, cutting an estimated $3.16M.
- 73 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q3 2021, up from 72 in Q2 2021.
- Funds reported $47.1M of Marrone Bio Innovations, Inc. stock for Q3 2021, down 48% quarter-over-quarter.
- 10 funds opened new Marrone Bio Innovations, Inc. positions in Q3 2021 and 8 closed out, a net change of +2 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q3 2021 was Oak Family Advisors, an estimated $751K added.
- The largest Marrone Bio Innovations, Inc. seller in Q3 2021 was Macquarie Group, an estimated $3.16M sold.
Based on aggregated 13F filings for Q3 2021.